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Summary
Ephs regulate growth cone repulsion, a process con-
trolled by the actin cytoskeleton. The guanine nucleo-
tide exchange factor (GEF) ephexin1 interacts with
EphA4 and has been suggested to mediate the effect
of EphA on the activity of Rho GTPases, key regula-
tors of the cytoskeleton and axon guidance. Using cul-
tured ephexin1−/− mouse neurons and RNA interfer-
ence in the chick, we report that ephexin1 is required
for normal axon outgrowth and ephrin-dependent
axon repulsion. Ephexin1 becomes tyrosine phos-
phorylated in response to EphA signaling in neurons,
and this phosphorylation event is required for growth
cone collapse. Tyrosine phosphorylation of ephexin1
enhances ephexin1’s GEF activity toward RhoA while
not altering its activity toward Rac1 or Cdc42, thus
changing the balance of GTPase activities. These
findings reveal that ephexin1 plays a role in axon
guidance and is regulated by a switch mechanism
that is specifically tailored to control Eph-mediated
growth cone collapse.*Correspondence: michael.greenberg@childrens.harvard.edu
7 These authors contributed equally to this work.Introduction
The establishment of precisely wired neuronal networks
between the approximately 1011 neurons in the central
nervous system (CNS) presents a tremendous challenge
for mammalian development. During ontogeny, newly
generated neurons must migrate to their appropriate
location within the brain. As they reach their final desti-
nation, these cells extend axons and form synapses
onto their targets to generate appropriate neuronal cir-
cuits. Each of these steps depends on the ability of
neurons to respond to a complex set of environmental
cues and modify their intrinsic maturation program.
Over the last decade, significant progress has been
made in identifying both the extracellular factors and
neuronal receptors that regulate neuronal development.
Such factors include secreted molecules such as sem-
aphorins, slits, and netrins, as well as membrane-asso-
ciated molecules such as ephrins (Dickson, 2002;
Huber et al., 2003). Neurons and their growth cones re-
spond to these guidance factors through the coordi-
nated regulation of a variety of intracellular processes
including endocytosis, protein and lipid transport, actin
cytoskeletal remodeling, the modulation of microtubule
dynamics, and protein synthesis and degradation. A
key, unresolved issue is how cell surface receptors pro-
mote these diverse cellular processes to elicit specific
cellular responses such as neuronal migration, growth
cone guidance, and synapse formation.
To begin to address this question, we investigated
the signaling mechanisms by which the Eph family of
receptor tyrosine kinases mediates cellular responses.
With 13 members in the mouse and human genomes,
Ephs can be divided into two subfamilies (EphA and
EphB) that together constitute the largest known family
of receptor tyrosine kinases. The Ephs and their li-
gands, the ephrins, are broadly expressed throughout
the developing nervous system (Flanagan and Vander-
haeghen, 1998; Palmer and Klein, 2003). Eph signaling
contributes to a wide variety of developmental pro-
cesses including early patterning events responsible
for hindbrain segmentation as well as the migration of
neural crest cells during development. The best-char-
acterized role of Eph signaling involves the guidance of
axons during neural development. Gene knockout ex-
periments have demonstrated a role for ephrin-Eph sig-
naling in the pathfinding of axons, including axons of
the corticospinal tract, the corpus callosum, and the
anterior commissure, as well as retinotectal map forma-
tion, motor axon projections to the periphery, and thala-
mocortical projections (Palmer and Klein, 2003).
Ephs likely mediate aspects of neural development
by controlling cytoskeletal function through regulation
of the Rho family GTPases, RhoA, Rac1, and Cdc42
(Penzes et al., 2003; Wahl et al., 2000; Winning et al.,
2002). These small, monomeric GTPases function as
molecular switches, cycling between an inactive GDP
bound state and an active GTP bound form in which
they activate downstream effectors (Van Aelst and
D’Souza-Schorey, 1997). Each of the Rho family mem-
Neuron
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gin cells. For example, in neuronal growth cones, acti-
wvated RhoA causes growth cone repulsion by enhanc-
ring actin cytoskeleton contractility, while Rac1 and
eCdc42 promote extension by inducing the formation of
cactin-based lamellipodia and filopodia, respectively.
Rho GTPase activation is controlled by the opposing
oactions of guanine nucleotide exchange factors (GEFs),
fwhich catalyze the exchange of GDP for GTP, and
pGTPase activating proteins (GAPs), which promote hy-
edrolysis of GTP to GDP. Recently, we identified a Dbl
wfamily GEF, termed ephexin1, which interacts with the
rcytoplasmic domain of EphA4 (Shamah et al., 2001).
eEphexin1 is highly expressed in the CNS during devel-
popment and is enriched in neuronal growth cones.
tWhen overexpressed in cells, ephexin1 activates RhoA,
iRac1, and Cdc42. The coexpression of activated
rEphA4 with ephexin1 enhances the ability of ephexin1
mto activate RhoA relative to its ability to activate Rac1
iand Cdc42, thereby promoting growth cone collapse.
However, the relative importance for axon guidance of
Rephexin1 compared to other GEFs and the mechanism
Gby which EphA signaling regulates ephexin1 activity re-
wmained to be determined.
fIn this study, we find that, in the absence of ephrin stim-
aulation, ephexin1 promotes axon growth. We also demon-
mstrate that ephexin1 is required for ephrin-A-induced
sgrowth cone collapse of retinal ganglion cells (RGC)
(and the Eph/ephrin-mediated stalling of spinal motor
1axons at the base of the limb in vivo. Thus, ephexin1 is
binvolved in the opposing processes of axonal outgrowth
tand growth cone collapse/repulsion. We have eluci-
vdated the mechanism by which Ephs control ephex-
0in1’s activity to mediate these processes. We find that,
iin the absence of ephrin stimulation, ephexin1 activates
RhoA, Rac1, and Cdc42, thus leading to a balance of
mGTPase activity that promotes outgrowth. Ephrin en-
cgagement of Ephs leads to phosphorylation of ephex-
ein1 on Tyr87. This phosphorylation event preferentially
pactivates ephexin1’s exchange activity toward RhoA
cbut not Rac1 and Cdc42, thus switching the substrate
epreference of ephexin1 and leading to growth cone col-
plapse. These findings reveal a new mode of phosphory-
p
lation-dependent GEF regulation and provide insight
e
into the mechanism by which EphA signaling controls
a
the actin cytoskeleton via ephexin1 phosphorylation. R
m
Results e
g
Ephexin1-Deficient RGCs Have a Deficit U
in Ephrin-A-Induced Growth Cone Collapse m
We have previously shown that EphA4 and ephexin1 l
interact when expressed in HEK293T cells (Shamah et e
al., 2001). In addition, overexpression of a dominant in- e
terfering form of ephexin1 in RGCs leads to an inhibi- w
tion of ephrin-induced growth cone collapse. Nonethe- 3
less, we have been unable to detect an interaction l
between endogenous EphAs and ephexin1 in neurons n
by coimmunoprecipitation, leaving open the possibility o
that, when overexpressed in neurons, inactive ephexin1 f
occludes the binding of a GEF other than ephexin1 that l
under physiological conditions is the actual mediator of g
tephrin-A-induced growth cone collapse. To address theuestion of whether ephexin1 mediates ephrin-A-induced
rowth cone collapse under physiological conditions,
e generated mice in which the ephexin1 gene is dis-
upted and asked whether, in ephexin1−/− neurons,
phrin-A is still effective at inducing RGC growth cone
ollapse.
ephexin1−/− mice were generated by standard meth-
ds (Figure S1A), were born at the expected Mendelian
requency, and were viable, fertile, and overtly normal,
ossibly due to the presence of other members of the
phexin family (see below). Western blot analyses of
hole brain lysates with any of four distinct antibodies
aised against either the N- or C-terminal domains of
phexin1 failed to detect the presence of ephexin1
rotein in ephexin1−/− mice (Figure 1A; Figure S1B). Fur-
hermore, immunohistochemistry of wild-type and ephex-
n1−/− brain sections revealed strong, specific immuno-
eactivity in the striatum and neocortex of wild-type
ice and no immunoreactivity in the brains of ephex-
n1−/− mice (Figure 1B).
As ephexin1 has previously been shown to activate
hoA, Rac1, and Cdc42 (Shamah et al., 2001) and these
TPases are known to be involved in axon extension,
e investigated whether ephexin1−/− RGCs have de-
ects in axon extension. We measured the length of the
xon in RGC cultures from wild-type and ephexin1−/−
ice. Axons from ephexin1−/− RGCs were significantly
horter than their counterparts from wild-type RGCs
Figure 2A; wild-type 151.9 ± 13.8 m versus ephexin1−/−
10.7 ± 8.4 m; p < 0.01 by ANOVA). However, the num-
er of neurites per cell was unaltered between wild-
ype and ephexin1−/− neurons (wild-type 3.87 ± 0.22
ersus ephexin1−/− 4.19 ± 0.11 neurites per cell; p =
.32 by ANOVA). These results suggest that ephex-
n1 plays a crucial role in axon outgrowth.
Our previous study had suggested that ephexin1
ight play a role in regulating ephrin-induced growth
one collapse in RGCs. To assess the importance of
phexin1 for EphA-mediated axon guidance, we com-
ared the ability of ephrin-A to induce growth cone
ollapse of RGCs obtained from either wild-type or
phexin1−/− mice. We used purified RGCs for these ex-
eriments, because both EphAs and ephexin1 are ex-
ressed in the ganglion cell layer of embryonic and
arly postnatal retina, and the ability of ephrins to medi-
te growth cone collapse has been well established in
GCs (Feldheim et al., 1998; Jurney et al., 2002; Sha-
ah et al., 2001). Purified RGCs from wild-type and
phexin1−/− mice have a similar percentage of intact
rowth cones prior to ephrin treatment (Figure 2B).
pon exposure to ephrin-A1, RGCs from wild-type
ice show a significant increase in the number of col-
apsed growth cones. By contrast, significantly fewer
phexin1−/− RGC growth cones collapse in response to
phrin-A1 (Figure 2B; percent uncollapsed mean ± SEM
ith ANOVA: wild-type, 30.4 ± 1.4; ephexin1−/−, 53.3 ±
.2; p < 0.01). This reduction in the percentage of col-
apsed growth cones in ephexin1−/− versus wild-type
eurons does not reflect an intrinsic defect in the ability
f RGCs to respond to repulsive factors; when RGCs
rom wild-type and ephexin1−/− mice were exposed to
ysophosphatidic acid (LPA), an agent that induces
rowth cone collapse via a G protein-coupled receptor
hat triggers RhoA activation (Moolenaar, 1999), we de-
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193Figure 1. Characterization of ephexin1−/− Mice
(A) Western blot demonstrating the absence of ephexin1 protein in ephexin1−/− mice. Vav-2, another Rho family GEF, serves as a loading
control.
(B) Immunohistochemistry of brain sections from wild-type and ephexin1−/− mice revealed specific staining in the striatum (str) and neocortex
of wild-type mice above the white matter (wm). There is no detectable staining in brain sections from ephexin1−/− mice.2C). We now refer to the original isolate as ephexin1been unable to detect a defect in axon pathfinding in
Figure 2. Ephexin1 Is Required for Ephrin-
Induced Growth Cone Collapse
(A) ephexin1−/− RGCs have shorter neurites
compared to RGCs from wild-type littermates.
These data represent four separate experi-
ments in which at least 50 neurites were
measured for each condition. All experi-
ments were scored in a blinded manner. All
error bars are standard error of the mean
(SEM); *p < 0.01.
(B) ephexin1−/− RGCs collapse less efficiently
in response to ephrin stimulation. However,
there is no difference between wild-type and
knockout cells in the percentage of collapsed
growth cones following LPA treatment.
These data represent three separate experi-
ments in which at least 100 growth cones
were scored for each condition. All experi-
ments were scored in a blinded manner. All
error bars are SEM; *p < 0.01.
(C) Schematic representation of the five mu-
rine ephexin family members. The SH3 do-
main is indicated in blue, the PH domain is
indicated in green, the DH domain is indi-
cated in red, and the conserved tyrosine mo-
tif at the N terminus is indicated in purple.
The numbers on the right indicate the num-
ber of amino acids contained in each full-
length ephexin family member.tected no significant difference in growth cone collapse
between wild-type and ephexin1−/− RGCs (Figure 2B).
Furthermore, levels of both phosphorylated and non-
phosphorylated Ephs were unaltered in ephexin1−/−
RGCs when compared to wild-type RGCs (data not
shown). These results suggest that, although the basic
cellular machinery that mediates growth cone forma-
tion and collapse is intact in ephexin1-deficient neu-
rons, EphA-mediated growth cone collapse is impaired
in the absence of ephexin1.
Since cultured RGCs from ephexin1−/− mice have de-
fects in axonal outgrowth as well as in ephrin-induced
growth cone collapse, we asked whether these pheno-
types would be recapitulated in vivo in ephexin1−/−
mice. However, by axon tracing experiments, we haveephexin1−/− retinogeniculate, retinocollicular, or corti-
cospinal tracts (data not shown). We suspected that the
absence of overt axonal phenotype in ephexin1−/− ani-
mals might be a result of compensation by other
ephexin family members. In our earlier study, we iden-
tified three human homologs of ephexin1 (Shamah et
al., 2001). Taking advantage of the recent publication of
the human genome sequences, we have now identified
an additional human ephexin family member (RET/
ARHGEF19). Using the BLAST program to search the
EST and genomic databases, we also identified four
mouse genes that are highly homologous to the original
mouse ephexin1. We named these human and mouse
genes ephexin2 through ephexin5 based on their se-
quence similarity to the original ephexin gene (Figure
Neuron
194and use the term ephexin family to refer to this group s
tof five mammalian genes. A comparison of the se-
quence of the five ephexin family members reveals that t
tthey share the same overall structure, including a Dbl
homology (DH) domain followed by a pleckstrin homol- e
pogy (PH) domain, and a C-terminal SH3 domain. How-
ever, the various members of the ephexin family have r
tunique N-terminal regions, which are variable in length
and have little sequence similarity. Examination of the b
ntissue distribution of the ephexin family members by
Northern blot and in situ hybridization revealed that C
fonly ephexin1 and ephexin5 (also known as Vsm-Rho-
GEF [Ogita et al., 2003]) mRNA are detected at signifi- c
gcant levels in P7 and P21 mouse brain (Figure S2).
E
fEphexin Is Expressed Differentially
rin Chick Motor Neuron Columns
dSince our analysis of ephexin1−/− mice appears to be
icomplicated by issues of compensation by other ephexin
family members, we searched for an organism with only
cone ephexin ortholog. We chose the chick embryo be-
ccause only a single ephexin is expressed, and EphA4
mand ephrins play important roles in the guidance and
upatterning of motor axons to their targets (Eberhart et
sal., 2002; Eberhart et al., 2004). At hindlimb levels, mo-
ttor neurons are organized into lateral and medial motor
Tcolumns [LMC and MMC(m)], respectively. While both
esubsets of neurons express EphA4, LMC and MMC(m)
oneurons respond differentially to ephrin-A5 (Eberhart et
aal., 2004). Axons of motor neurons in the lateral portion
fof the LMC are repelled by ephrin-A5 in limb meso-
aderm, whereas MMC(m) axons extend readily into
tephrin-A5-expressing somitic mesoderm. We consid-
3ered the possibility that the differential response of
qLMC and MMC(m) axons to ephrin-A might reflect dif-
vferences in the ability of EphA4 to signal to ephexin.
dTo determine if ephexin protein is differentially ex-
ipressed in LMC and MMC(m) neurons, we examined its
wdistribution using an anti-chicken ephexin antibody. En-
tdogenous chicken ephexin (c-ephexin) localizes to LMC
neurons but is absent from MMC(m) neurons (Figure 3A).
This observation raised the possibility that c-ephexin may E
account for the differential responses of these motor f
axons to ephrins. MMC(m) neurons may extend axons W
readily into the ephrin-A5-positive somitic mesoderm e
because they lack c-ephexin, while LMC axons that ex- o
press c-ephexin might be prohibited from entering the t
ephrin-expressing limb mesoderm. If LMC axons utilize t
c-ephexin in their inhibitory response, then one would k
predict that the loss of c-ephexin would result in the t
premature entry of LMC axons into the limb mesoderm. w
i
eMotor Axons Sort and Enter the Limb Prematurely
When c-Ephexin Levels Are Reduced i
tTo test whether c-ephexin plays a role in the LMC axon
pathfinding, we generated two shRNA constructs di- a
urected against c-ephexin, transfected them into chick
neural tubes, and examined their effect on motor neu- R
fron projections. We first tested the ability of these
shRNA constructs to knock down c-ephexin in m
iHEK293T cells and found that they significantly re-
duced c-ephexin protein levels compared to control C
lconstructs (Figure 3B), indicating that our shRNA con-tructs reduce c-ephexin protein levels in vitro. To de-
ermine whether c-ephexin is required for LMC axons
o stall at the base of the limb, the right side of neural
ubes from stage 17 embryos was transfected with
ither of two c-ephexin shRNA constructs and an EGFP
lasmid. To ascertain whether c-ephexin protein was
educed in transfected neurons, transverse sections
hrough embryos were stained with anti-c-ephexin anti-
ody and Islet-1/2 antibody, to mark postmitotic motor
eurons, followed by quantification of pixel intensity.
-ephexin protein levels are reduced in neurons trans-
ected with c-ephexin shRNA/EGFP, compared with
ontrol conditions (Figure 3C). Motor neurons were
enerated in their appropriate position and number;
phA4 protein levels were unaltered in neurons trans-
ected with c-ephexin shRNA (data not shown). These
esults demonstrate that shRNA against c-ephexin re-
uces c-ephexin protein specifically in LMC neurons
n vivo.
We next examined the effects of knocking down
-ephexin on the projections of LMC neurons. When
-ephexin levels are reduced, motor axons extend pre-
aturely into the limb mesoderm (n = 6 embryos; Fig-
res 3D and 3E). In addition, EphA4 protein becomes
egregated early to a subset of motor axons, localizing
o the forming dorsal nerve trunk (Figures 3D and 3E).
hree sets of controls were examined: (1) motor axons
xpressing EGFP alone (n = 5 embryos); (2) motor ax-
ns transfected with missense shRNA constructs
gainst c-ephexin (n = 5 embryos); and (3) nontrans-
ected, contralateral motor axons (n = 12 embryos). In
ll three controls, motor axons remained at the base of
he limb and did not enter limb mesoderm early (Figures
D and 3E). These results indicate that c-ephexin is re-
uired in LMC axons in vivo to elicit their stalling beha-
ior at the base of the hindlimb mesoderm. Having
emonstrated that ephexin is required for Eph signaling
n vivo, we sought to understand the mechanism by
hich Ephs signal to ephexin to regulate the actin cy-
oskeleton.
ph Kinase Activity Is Required
or Regulating Ephexin1
e found that treating cultured RGCs with clustered
phrin-A1 leads to growth cone collapse and that to
ccur normally this process requires ephexin1. Since
reatment with clustered ephrins induces the aggrega-
ion of Ephs, leading to the induction of EphA tyrosine
inase activity, it was possible that either the aggrega-
ion of EphA or the induction of EphA kinase activity
as responsible for ephexin1 activation. To determine
f the tyrosine kinase activity of Ephs is required for
phexin1 activation, we introduced EphA4 and ephex-
n1 into fibroblasts and monitored the ability of EphA4
o regulate ephexin1-dependent RhoA, Rac1, and Cdc42
ctivation. Fibroblasts provide a facile system for eval-
ating the effects of EphA and ephexin1 on RhoA,
ac1, and Cdc42 activity, as activation of these Rho
amily GTPases triggers specific changes in fibroblast
orphology that can be visualized by phalloidin stain-
ng. In fibroblasts, RhoA induces stress fiber formation,
dc42 causes filopodia extension, and Rac1 triggers
amellipodia formation and membrane ruffling (Nobes
Eph-Dependent Tyrosine Phosphorylation of Ephexin
195Figure 3. Chick Motor Neuron Axons Sort
and Enter the Hindlimb Prematurely When
Ephexin Is Knocked Down
(A) Expression of chick ephexin in the neural
tube (nt) using an anti-chick ephexin anti-
body. Labeling localizes to motor neurons in
the lateral motor column (LMC) but not the
medial motor column [MMC(m)]. C-ephexin
protein is also present in the forming dorsal
root ganglia (DRG) and the myotome.
(B) shRNAs directed against c-ephexin re-
duce c-ephexin protein levels in HEK293T
cells. Cells were transfected with c-ephexin
(lane 1), c-ephexin and shRNA vector (lane
2), c-ephexin and shRNA 461 (lane 3), or
c-ephexin and shRNA 218 (lane 4). Lysates
were probed with antibodies against
c-ephexin and actin, which serves as a load-
ing control.
(C) shRNA directed against c-ephexin re-
duces c-ephexin protein levels in chick neu-
ral tubes. Average pixel intensity following
immunohistochemistry with anti-c-ephexin
antibody for stage 23 presumptive LMC mo-
tor neurons was calculated for transfected
and untransfected sides of chick embryos.
shRNA directed against chick ephexin (“E”;
n = 5), missense shRNA (“M”; n = 4), and
EGFP-expressing vector (“V”; n = 2) were
compared for ephexin expression. The y axis
denotes the ratio of average pixel intensity
between transfected and untransfected sides.
shRNAs directed against chicken ephexin
specifically reduce ephexin protein levels. All
error bars are SEM; *p < 0.0001.
(D) Top: Motor axons that express ephexin
shRNAs sort and project into the hindlimb
prematurely. White dashed line demarcates
the base of the limb, which was determined by the expression of EphA4 in limb mesoderm. (Left) Motor axons treated with ephexin shRNAs
express EGFP (green); (middle) EphA4 protein (red) decorates the forming dorsal nerve trunk; (right) neurofilament antibody labeling (blue)
marks all motor axons. Bottom: Nontransfected motor axons stall at the base of the limb. EphA4 protein (middle; red) and neurofilament
antibody (right; blue) mark all motor axons in the spinal nerve.
(E) Three optical sections acquired from the same embryo, treated with ephexin shRNAs on the right neural tube (nt). Left neural tube is not
transfected. White dashed line indicates base of hindlimb; no, notochord. Top: EGFP expression (green) localizes to most cells in the ventral
neural tube and several motor axons that have projected to the limb. Middle: EphA4 protein (red) becomes segregated to a subset of axons
(arrow), in the presence of ephexin shRNAs. Note that all motor axons on the nontransfected side express EphA4. Bottom: Neurofilament
antibody (blue) labels ephexin shRNA-transfected and nontransfected motor axons.and Hall, 1995). We have previously shown that, when
expressed in REF-52 fibroblasts, ephexin1 induces
morphologic changes consistent with the activation of
the GTPases RhoA, Cdc42, and Rac1 (Shamah et al.,
2001; Figure 4A). However, when EphA4 is coexpressed
with ephexin1 in REF-52 cells, there is an increase in
the percentage of cells displaying stress fibers (RhoA
phenotype) and a decrease in the percentage of cells
with lamellipodia and filopodia (Rac1 and Cdc42 phe-
notypes, respectively). These results suggest that
EphA4 enhances the ability of ephexin1 to activate
RhoA and/or inhibits ephexin1 activation of Rac1 and
Cdc42, thus resulting in a shift in the balance of Rho
GTPase activities.
To test whether the kinase activity of EphA4 is re-
quired for this shift in GEF activity, we generated a point
mutation in EphA4, which renders it kinase inactive. In
contrast to wild-type EphA4, expression of the kinase-
inactive EphA4 did not affect the percentage of ephex-
in1-expressing cells exhibiting RhoA, Rac1, and Cdc42
phenotypes (Figure 4A). These findings indicate thatthe kinase activity of EphA4 is necessary for the ability
of EphA to modulate ephexin1 GEF activity. As cells
expressing equal levels of wild-type or kinase-inactive
EphA4 showed no obvious differences in the level of
ephexin1 expression, ephexin1 subcellular localization,
or ephexin1 association with EphA4 (data not shown),
we focused our attention on the possibility that, upon
activation, EphA4 might lead to the phosphorylation
of ephexin1 and thereby might modulate ephexin1
function.
Ephexin Family Members Contain a Conserved
Phosphorylation Site
Reasoning that sites of phosphorylation that play an
important role in regulating ephexin1 function would be
conserved throughout evolution, we identified tyrosine
residues within the ephexin family that are conserved
and might therefore represent regulatory phosphoryla-
tion sites. By comparing the sequences of the five
mammalian ephexins and the chicken, Drosophila, and
C. elegans ephexin orthologs, we identified a single ty-
Neuron
196Figure 4. Phosphorylation of a Conserved N-Terminal Tyrosine Residue of Ephexin1
(A) REF-52 cells transfected with wild-type or kinase-dead EphA4 and ephexin1. Cells were stained with fluorescent phalloidin and scored in
a blinded manner for the presence of stress fibers (white bars), lamellipodia (hatched bars), and filopodia (black bars). All transfections were
repeated three times, and at least 120 cells were scored in a blinded manner for each condition. All error bars are SEM.
(B) Sequence alignment of the Mus musculus, Gallus gallus, Drosophila melanogaster, and Caenorhabditis elegans ephexin family members
reveals a conserved N-terminal motif (highlighted in red). The first tyrosine in this motif is conserved in all family members.
(C) In vitro kinase assays with Src and trkB. Wild-type ephexin1 or ephexin1-Y87F were used as substrates for the kinases. Samples were
electrophoresed on an SDS-PAGE gel, which was subsequently stained with Coomassie blue to demonstrate equal loading and exposed to
film. Autoradiograph (top); Coomassie staining (bottom).
(D) Verification that Tyr87 is phosphorylated in ephexin1. Ephexin1 that was phosphorylated in vitro was subjected to tryptic digestion and
Edman degradation. Graph represents scintillation count associated with each amino acid as it was released by Edman degradation.rosine corresponding to amino acid 87 (Tyr87) of ephex- a
min1 that is present in the unique N-terminal region of
ephexin1 and is conserved between all ephexin family c
wmembers (Figure 4B). Analysis using the Scansite phos-
phorylation prediction program revealed that Tyr87 lies t
twithin a stretch of amino acids that form a consensus site
for Src family kinase phosphorylation (http://scansite. g
pmit.edu/). As EphA4 is similar to Src in its substrate
preference, we considered the possibility that ephexin1 t
Tyr87 is a site of phosphorylation by the Eph kinase
and/or a Src family member. t
oTo test if Tyr87 can be phosphorylated by Src or
EphA4, we incubated recombinant Src or the EphA4 ki- p
pnase domain in the presence of [γ-32P]ATP and either
wild-type ephexin1 or a mutant form of ephexin1 in t
awhich Tyr87 was mutated to phenylalanine (ephexin1-
Y87F). Under these conditions, wild-type ephexin1 was p
tefficiently phosphorylated by both Src and the EphA4
kinase domain, but not by trkB (Figure 4C; Figure S3). f
bMutation of Tyr87 to phenylalanine abolishes ephex-
in1’s ability to be phosphorylated by EphA4 and Src. t
wAlthough these results suggest that Tyr87 is the site
of EphA4/Src phosphorylation on ephexin1, it remained l
tpossible that mutation of Tyr87 to phenylalanine interferes
with the phosphorylation of ephexin1 on a neighboring emino acid. Therefore, we used direct sequencing
ethods to identify which residue on ephexin1 be-
omes phosphorylated following in vitro incubation
ith Src. To this end, ephexin1 was phosphorylated in
he presence of [γ-32P]ATP and Src in vitro, and the
ryptic peptide carrying the radioactive phosphate
roup was isolated by HPLC. Analysis of this tryptic
eptide by Edman degradation confirmed that Tyr87 is
he site of phosphorylation on ephexin1 (Figure 4D).
Since several commercially available anti-phospho-
yrosine antibodies failed to detect the phosphorylation
f Tyr87 on ephexin1, we generated an anti-ephexin1
hospho-Tyr87-specific antibody to monitor the phos-
horylation status of Tyr87 of ephexin1 within cells. To
est the specificity of the anti-ephexin1 phospho-Tyr87
ntibody, we compared the antibody’s affinity for phos-
horylated and nonphosphorylated ephexin1 peptides
hat encompass amino acids 81 to 93 of ephexin1. We
ound that the anti-ephexin1 phospho-Tyr87 antibody
inds effectively to phospho-ephexin1 peptide, but not
o nonphosphorylated peptide (Figure 5A). To assess
hether the anti-ephexin1 phospho-Tyr87 antibody se-
ectively recognizes Tyr87 phosphorylation in the con-
ext of full-length ephexin, we incubated wild-type
phexin1 or ephexin1-Y87F with ATP and recombinant
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(A) Slot blot analysis of phosphorylated (P) and nonphosphorylated (NP) peptides using the anti-ephexin1 phospho-tyrosine 87-specific
antibody. Each slot represents a 10-fold higher concentration of peptide over the one to its left.
(B) Western blots of recombinant ephexin1 phosphorylated in vitro by Src, using anti-ephexin1 phospho-tyrosine 87-specific antibody. Immu-
noreactivity is detected with Src and ephexin1, but not ephexin1 alone or ephexin1-Y87F and Src, demonstrating the specificity of the anti-
ephexin1 phospho-tyrosine 87 antibody.
(C) Ephexin1 is phosphorylated in neurons in response to ephrin treatment. Primary rat striatal neurons were cultured for 4 days and stimulated
for the indicated amount of time with ephrin-A1. Lysates were probed with anti-ephexin1 phospho-tyrosine 87-specific (top panel) and total
ephexin1 (bottom panel) antibodies. Ephexin1 tyrosine phosphorylation can be detected as early as 1 min after stimulation.
(D) Cultured primary striatal neurons from wild-type and ephexin1−/− mice were stimulated for the indicated amount of time with ephrin-A1.
Lysates were probed with anti-ephexin1 phospho-tyrosine 87-specific antibody. Ephexin1 phosphorylation can be detected in wild-type
neurons but not in ephexin1−/− neurons.
(E) Ephexin1 is phosphorylated specifically by ephrins. Primary rat striatal neurons were cultured for 4 days and stimulated with the indicated
agents. Lysates were probed with anti-ephexin1 phospho-tyrosine 87-specific antibody, total ephexin1, and phospho-EphA antibodies.
(F) Inhibitors of Src family kinases block ephexin1 phosphorylation on Tyr87 without blocking activation of the Eph tyrosine kinases. Primary
rat striatal neurons were cultured for 4 days and stimulated with Fc alone (first lane) or with ephrin-A1-Fc in the presence of no inhibitor
(second lane), PP3, PP2, DMSO, or SU6656 (SU). Western blots were probed with anti-ephexin1 phospho-tyrosine 87-specific antibody,
phospho-EphA, and total ephexin1 antibodies.Src and examined the anti-ephexin1 phospho-Tyr87 an-
tibody’s binding to ephexin1 by Western blotting. We
found that the anti-ephexin1 phospho-Tyr87 antibody
specifically detects Tyr87 phosphorylated ephexin1,
but not the ephexin1-Y87F mutant or nonphosphory-
lated wild-type ephexin1 (Figure 5B).
Ephrin Stimulation Results in Rapid Tyrosine
Phosphorylation of Ephexin1 in Neurons
Given the importance of ephexin1 for ephrin-A-induced
growth cone collapse in cultured neurons, we utilized
the anti-ephexin1 phospho-Tyr87 antibody to deter-
mine whether ephexin1 is phosphorylated in response
to EphA signaling in primary neuronal cultures. The
anti-ephexin1 phospho-Tyr87 antibody recognized a
protein of the appropriate molecular weight (75 kDa) in
ephrin-A1-treated neurons (Figure 5C). To confirm that
this protein is ephexin1, we compared lysates from
wild-type and ephexin1−/− neurons. Importantly, no 75kDa band is seen in the neuronal lysates from ephex-
in1−/− mice, even though Ephs are activated to the
same extent as in wild-type neurons (Figure 5D; data
not shown), suggesting that the 75 kDa band recog-
nized by the anti-ephexin1 phospho-Tyr87 antibody
upon ephrin-A treatment is the Tyr87 phosphorylated
form of ephexin1. Using this antibody, we found that
ephrin-A1 stimulation induces the phosphorylation of
Tyr87 on ephexin1 in cultured neurons within 1 min (Fig-
ure 5C). Ephexin1 phosphorylation peaks at 5 min and
begins to diminish by 30 min (Figure 5C; data not
shown), paralleling the time course of growth cone col-
lapse and reextension in these cultures. To determine
whether ephexin1 Tyr87 phosphorylation can be in-
duced by extracellular stimuli in addition to ephrin-A,
we characterized the phosphorylation of ephexin1 on
Tyr87 after exposure of neurons to several other extra-
cellular factors. Ephrin-A1 and ephrin-B3 stimulation in-
duced ephexin1 phosphorylation, while LPA, Sema-3a,
Neuron
198and Nogo did not induce the phosphorylation of this i
asite, despite the ability of these agents to induce
growth cone collapse (Figure 5E). Furthermore, other l
pstimuli, such as BDNF, EGF, PDGF, and forskolin, did
not result in the phosphorylation of ephexin1 on Tyr87 c
d(data not shown). These observations demonstrate that
ephexin1 Tyr87 phosphorylation occurs specifically in p
gresponse to ephrin stimulation and correlates with the
onset of ephrin-induced growth cone collapse, sug- s
pgesting a specific role for this phosphorylation event in
the process of Eph-dependent growth cone navigation. q
e
tEphexin1 Is Phosphorylated in Neurons
cby Src Family Kinases
In vitro, both recombinant Src and the EphA4 kinase
sdomain are able to phosphorylate ephexin1. To assess
tthe importance of Src activation for ephrin-A1-induced
sephexin1 phosphorylation in vivo, we took advantage of
etwo small molecule inhibitors of the Src family of tyrosine
6kinases, PP2 and SU6656. Both PP2 and SU6656, but
lnot PP3, the inactive analog of PP2, inhibited ephrin-
wA1-induced ephexin1 Tyr87 phosphorylation in cultured
irat striatal neurons (Figure 5F). To ensure that, at the
gconcentrations used, the pharmacological inhibitors
uwere not inhibiting Eph tyrosine kinases, we titrated the
concentration of the inhibitors to a level that did not
caffect ephrin-induced Eph phosphorylation in cultured
pneurons. We found that PP2 at 0.5 M and SU6656 at
p1 M were specifically able to inhibit ephexin1 phos-
tphorylation on Tyr87 but did not inhibit Eph tyrosine
pphosphorylation (Figure 5F). These findings suggest
tthat ephrin-A1 binding to EphA leads to phosphoryla-
etion of ephexin1 at Tyr87 by activating Src family ki-
Enases. Consistent with our findings, Drescher and col-
fleagues have recently reported that Src family kinases
Acan phosphorylate ephexin1 in cultured neurons in re-
asponse to ephrins (Knoll and Drescher, 2004).
t
Tyrosine Phosphorylation of Ephexin1 Contributes
to Growth Cone Collapse T
PTo determine whether phosphorylation of ephexin1 at
Tyr87 is required for ephrin/Eph-dependent growth W
pcone collapse, we transfected RGCs with wild-type and
nonphosphorylatable forms (Y87F) of ephexin1 and an- u
Ealyzed the effect of these GEFs on ephrin-induced
growth cone collapse. We have previously shown that m
aectopic expression of ephexin1 significantly potenti-
ates ephrin-mediated growth cone collapse and that t
lthe GEF activity of ephexin1 is necessary for this effect
(Shamah et al., 2001). While expression of wild-type t
wephexin1 or ephexin1-Y87F did not significantly alter
the percentage of collapsed growth cones in unstim- o
eulated RGCs, RGCs expressing wild-type ephexin1 ex-
hibited an increased percentage of collapsed growth d
acones in response to ephrin-A1 as compared to RGCs
expressing vector alone (Figure 6A). In contrast, ephrin r
cstimulation of RGCs expressing ephexin1-Y87F re-
sulted in no increase in the percentage of growth cones i
othat collapse when compared to RGCs expressing vec-
tor alone (Figure 6A). To determine whether an indepen- a
sdent way of phosphorylating ephexin1 was sufficient
to induce growth cone collapse, we sought to identify t
tconditions under which ephexin1 was phosphorylatedndependently of ephrin stimulation. Since no other
gent that we tested was able to induce the phosphory-
ation of Tyr87 on ephexin1, we sought to induce the
hosphorylation of ephexin1 in neurons by blocking
ellular tyrosine phosphatases. We found that pervana-
ate treatment of cultured neurons induced the phos-
horylation of ephexin1 on Tyr87 and resulted in strong
rowth cone collapse response (Figure 6A; data not
hown). Furthermore, pervanadate-treated RGCs ex-
ressing wild-type ephexin1 exhibited an increased fre-
uency of growth cone collapse as compared to those
xpressing ephexin1-Y87F or vector alone, suggesting
hat pervanadate-induced phosphorylation of ephexin1
an also stimulate growth cone collapse (Figure 6A).
To the limit of our detection, we see no difference in
ubcellular localization or level of expression of wild-
ype ephexin1 and ephexin1-Y87F in RGCs (data not
hown). Furthermore, both wild-type ephexin1 and
phexin1-Y87F bind EphA4 to a similar degree (Figure
B). Thus, the observed difference in growth cone col-
apse between wild-type ephexin1 and ephexin1-Y87F
as not a result of the mutant’s aberrant localization or
nability to bind Eph. Taken together, these data sug-
est that phosphorylation of ephexin1 at Tyr87 contrib-
tes to Eph-mediated growth cone collapse.
RGCs expressing ephexin1-Y87F did not show de-
reased growth cone collapse compared to RGCs ex-
ressing vector alone in response to either ephrin or
ervanadate treatment. These data suggest that under
he conditions of these experiments ectopically ex-
ressed ephexin1-Y87F may not interfere with the func-
ion of endogenous ephexin1. This may be because the
ndogenous ephexin1 is found in a stable complex with
phs within cells and is not turned over within the time
rame of the growth cone collapse experiments (24 hr).
lternatively, we may not be expressing ephexin1-Y87F
t high enough levels to interfere with the function of
he endogenous ephexin1.
yrosine Phosphorylation of Ephexin1 Mediates Cell
ositioning in a Chick Spinal Cord
e next examined the role of ephexin1 tyrosine phos-
horylation in vivo in the context of neural development
sing the chick embryo. To assess whether ephrin-A/
phA induction of ephexin tyrosine phosphorylation
ight be important for the proper development of LMC
nd/or MMC(m) neurons, we examined the effect of ec-
opic expression of either wild-type or a nonphosphory-
atable mutant form of c-ephexin (c-ephexinY17F) on
he behavior of motor neurons within the neural tube. It
as difficult to examine the effect of ephexin on axon
utgrowth and guidance because neurons ectopically
xpressing c-ephexin and EphA4 appear round and
o not extend axons. Therefore, we concentrated our
nalysis on the migration and localization of motor neu-
ons within the neural tube. Wild-type or Y17F mutant
-ephexin together with EphA4/EGFP were expressed
n presumptive motor neurons in the ventral quadrant
f the neural tube, as previously described (Eberhart et
l., 2002; Krull, 2004). In control embryos, EGFP expres-
ion marks elongated neuroepithelial cells in the neural
ube (Figure 7A). Ectopic expression of EphA4, wild-
ype c-ephexin, or c-ephexin-Y17F in the ventral neural
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(A) Purified RGCs were transfected with either vector alone (white bars), wild-type ephexin1 (hatched bars), or ephexin1-Y87F (black bars).
Growth cone collapse was scored in a blinded manner for control, ephrin-A1-treated, and pervanadate-treated neurons. The data represent
three separate experiments in which at least 100 growth cones were scored. All error bars are SEM; *p < 0.001; p < 0.002.
(B) Ephexin1-Y87F interacts with EphA4. The indicated constructs were transfected into HEK293T cells, and anti-ephexin1 immunoprecipi-
tations were performed. Blots were probed with anti-EphA4 and anti-ephexin1 antibodies.tube does not alter the positioning of motor neurons
(data not shown; Eberhart et al., 2002). However, when
EphA4/EGFP was expressed together with wild-type
c-ephexin, many transfected neural tube cells prema-
turely exited the neural tube laterally, 24 hr after trans-
fection (Figures 7B, 7C, and 7D). This aberrant migra-
tion was dependent on c-ephexin phosphorylation, as
cells expressing EphA4/EGFP together with the c-ephexin-
Y17F mutant did not migrate laterally but remained
adjacent to the lumenal surface of the neural tube (Fig-
ures 7B, 7E, and 7F). Thus, ephrin-A/EphA induction of
c-ephexin tyrosine phosphorylation can affect the lo-
calization of motor neurons and possibly other neural
tube cells. Taken together with the observation that en-
dogenous c-ephexin is restricted to LMC neurons in the
developing spinal cord and our shRNA findings, these
results suggest that EphA signaling through c-ephexin
contributes to the proper localization of motor neurons
in the ventral neural tube and to the targeting of their
axons during spinal cord development.
Eph Modulation of Ephexin1 GEF Activity Requires
Tyrosine Phosphorylation
Having found that ephexin1 tyrosine phosphorylation
contributes to ephexin1 function in axon guidance and
neuronal localization, we investigated the mechanism
by which ephexin1 phosphorylation alters ephexin1 ac-
tivity. To this end, we first determined which domains of
ephexin1 confer specificity for the different Rho family
GTPases. Upon expression of the catalytic domain of
ephexin1, which is composed of the DH and PH domains,
transfected REF-52 cells exhibit a predominantly RhoA-
like phenotype, similar to that observed following acti-
vation of wild-type ephexin1 by EphA signaling (Figure
8A). As full-length ephexin1 activates RhoA, Rac1, and
Cdc42, these results demonstrate that domains outside
of the DH-PH domain confer substrate specificity on
ephexin1. Furthermore, coexpression of EphA4 with
ephexin1-DH-PH does not significantly affect the GEFactivity of the catalytic domain, suggesting that addi-
tional ephexin1 domains are required to confer respon-
siveness to EphA signaling.
To determine which domains confer specificity on
ephexin1, we generated a C-terminal truncation mutant
of ephexin1 containing amino acids 1–518 only (ephex-
in1C). This construct was able to induce RhoA, Rac1,
and Cdc42 in REF-52 cells, and coexpression of EphA4
and ephexin1C results in cells that exhibit a predomi-
nantly RhoA phenotype (data not shown). As the C termi-
nus is not required to confer substrate specificity on
ephexin1, we generated an N-terminal truncation mutant
of ephexin1 (ephexin1N) lacking amino acids 1–183
including the site of ephexin1 tyrosine phosphorylation.
Cells expressing ephexin1N exhibit a predominantly
RhoA-like phenotype, mimicking the effect of the iso-
lated ephexin1 catalytic domain (Figure 8A). Coexpres-
sion of EphA4 with ephexin1N had no effect on the
percentage of cells displaying a RhoA, Rac1, or Cdc42
phenotype when compared to cells expressing ephex-
in1N alone. These results suggest that the N-terminal
domain of ephexin1 acts to regulate ephexin1 GEF ac-
tivity toward RhoA, Rac1, and Cdc42 and that phos-
phorylation of ephexin1 on Tyr87 in response to EphA
activation might change ephexin1’s substrate prefer-
ence toward the three GTPases.
To test this hypothesis, we used the fibroblast mor-
phology assay to assess the effect of wild-type ephex-
in1 and ephexin1-Y87F on RhoA, Rac1, and Cdc42 ac-
tivity. When wild-type ephexin1 and ephexin1-Y87F
were expressed in REF-52 fibroblasts, they were equ-
ally effective at activating RhoA (Figure 8B). Coexpres-
sion of EphA4 with wild-type ephexin1 led to an increase
in the percentage of cells that exhibit a RhoA-like pheno-
type, while the percentage of cells displaying Rac1 and,
to a lesser extent, Cdc42 phenotypes was diminished.
In contrast, the coexpression of EphA4 with the non-
phosphorylatable ephexin1 mutant (Y87F) had no effect
on ephexin1-Y87F GEF activity toward RhoA (Figure
8B). Taken together, these data show that the N termi-
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fFigure 7. Phosphorylation of Ephexin1 Modulates Spinal Motor
bNeuron Localization
t(A) Twenty-four hours after electroporation, neuroepithelial cells ex-
wpressing EGFP (green) in control embryos demonstrate an elon-
(gated morphology, extending processes from the lumenal to pial
asurface (arrow). Islet-1/2-positive neurons are shown in red.
d(B) Quantification of the mean number of cells outside the neural
Rtube when c-ephexin or c-ephexinY17F is coexpressed with
mEphA4. Five embryos were analyzed for each condition. *p < 0.001.
(C and D) After 24 hr, cells coexpressing c-ephexin1/EGFP and
EphA4/EGFP typically migrate aberrantly beyond the neural tube
p(arrows) and are often found misplaced in lateral positions.
(E and F) In the presence of c-ephexin1Y17F/EGFP and EphA4/ c
EGFP, labeled cells do not migrate laterally but are found adjacent
to the lumenal surface of the neural tube. r
oigure 8. Phosphorylation of Ephexin1 Modulates Its GEF Activity
oward Different GTPases
A and B) REF-52 cells were transfected with the indicated con-
tructs. Cells were stained with fluorescent phalloidin and scored
or the presence of stress fibers (white bars), lamellipodia (hatched
ars), and filopodia (black bars). All transfections were repeated six
imes, and at least 100 cells were scored for each experiment. Cells
ere scored in a blinded manner. All error bars are SEM.
C) In vitro GDP release assay with recombinant proteins. Ephexin1
nd ephexin1-Y87F were incubated with Src or GST prior to con-
ucting the GDP release assay. GDP release was performed on
hoA, Rac1, and Cdc42. Data represent three individual experi-
ents, and all error bars are SEM (*p < 0.002 by ANOVA).fnus of ephexin1 regulates its GEF activity and that the
phosphorylation of ephexin1 on Tyr87 increases ephex- c
fin1’s GEF activity toward RhoA relative to Rac1 and
Cdc42. However, the experiments in REF-52 cells re- c
pflect the balance of all GTPases activated in the cell
and thus do not distinguish between the following pos- r
csibilities: (1) phosphorylation of ephexin1 could increase
ephexin1’s GEF activity toward RhoA and not change c
eits activity toward Rac1 or Cdc42, (2) phosphorylation
of ephexin1 could increase ephexin1’s GEF activity to- t
Cward RhoA while inhibiting its activity toward Rac1 or
Cdc42, (3) phosphorylation of ephexin1 could suppress l
fephexin1’s GEF activity toward Rac1 or Cdc42 and not
change its activity toward RhoA. Any of these three rossibilities could account for the observed REF-52
ell morphologies.
To distinguish between these possibilities, we di-
ectly assessed the effect of phosphorylation of Tyr87
n ephexin1’s ability to catalyze the exchange of GDP
or GTP on RhoA, Rac1, and Cdc42. We expressed re-
ombinant ephexin1 and ephexin1-Y87F fused to GST
rom baculovirus-infected cells and tested the ex-
hange activity of ephexin1 before and after in vitro
hosphorylation by recombinant Src. In the in vitro GDP
elease assay, increased release of GDP from ephexin1
orrelates with increased exchange activity. The ex-
hange activity of wild-type ephexin1 toward RhoA was
nhanced upon in vitro phosphorylation by Src, while
he exchange activity of ephexin1 toward Rac1 and
dc42 was not significantly altered by Src phosphory-
ation (Figure 8C). To assess whether the observed ef-
ect of Src on the exchange activity of ephexin1 is a
esult of phosphorylation, we tested the effect of Src
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of GTP for GDP on RhoA, Rac1, and Cdc42. We found
that Src had no effect on the exchange activity of ephex-
in1-Y87F.
To ensure that what we observe in vitro accurately
reflects what occurs in cells, we performed GDP re-
lease assays with lysates from transfected cells. We
find that lysates from cells expressing ephexin1 and
EphA4 exhibit higher exchange activity toward RhoA
than lysates from cells expressing ephexin1 alone. This
increase in exchange activity in the presence of EphA4
expression does not occur in lysates from cells ex-
pressing ephexin1-Y87F (data not shown). Thus, phos-
phorylation of ephexin1 at Tyr87 results specifically in
an increase in ephexin1’s GEF activity toward RhoA.
Although this is the first example of a GEF changing
its substrate preference in response to an extracellular
stimulus, there are some recent examples of GAPs
demonstrating such a switch. MgcRacGAP, which is a
GAP for Rac/Cdc42, is converted to a RhoGAP upon
phosphorylation by Aurora B kinase (Minoshima et al.,
2003). Phosphorylation of mgcRacGAP by Aurora ki-
nase increases the GAP activity of mgcRacGAP toward
RhoA but not toward Rac1 or Cdc42.
We conclude that the phosphorylation of ephexin1
at Tyr87 within the N terminus of ephexin1 modulates
ephexin1’s GEF activity toward RhoA, Rac1, and
Cdc42. However, rather than acting to generally sup-
press GEF activity, the ephexin1 N-terminal region reg-
ulates the substrate preference of ephexin1. Phosphor-
ylation of ephexin1 on Tyr87 in response to ephrin-A/
EphA signaling potentiates ephexin1-mediated activa-
tion of RhoA relative to Rac1 and Cdc42, thereby
changing the local balance of Rho GTPase activity
within cells. The switch in specificity may allow ephex-
in1 to promote axonal outgrowth in the absence of
ephrin and growth cone repulsion when an Eph-
expressing growth cone contacts ephrin-expressing
cells. Consistent with this idea, ephexin1−/− neurons
have reduced axonal outgrowth in the absence of
ephrin and impaired growth cone collapse when treated
with clustered ephrins.
Discussion
In the current study, we have tested the hypothesis that
ephexin1 is required for ephrin-A-induced growth cone
collapse and have elucidated a mechanism by which
ephrin-A triggers ephexin1-dependent axon guidance.
We find that chicken motor neurons in which ephexin
protein has been knocked down by RNAi project pre-
maturely into the hindlimb, indicating that ephexin
plays a critical role in Eph-mediated axon guidance in
vivo. In addition, we find that cultured RGCs from
ephexin1−/− mice have significantly shorter axons, and
their growth cones show reduced growth cone collapse
in response to ephrin-A1 stimulation as compared with
wild-type RGCs. These seemingly contrasting results—
that ephexin1 is required for axonal outgrowth as well
as for growth cone repulsion/collapse—are reconciled
by our findings regarding the regulation of ephexin1 ac-
tivity.
In the absence of ephrin, ephexin1 Tyr87 is not phos-phorylated, and under these conditions, Eph bound
ephexin1 activates RhoA, Rac1, and Cdc42, leading to
a balance of GTPase activation that promotes axonal
outgrowth. Consistent with this idea, RGCs that lack
ephexin1 have shorter axons than wild-type RGCs.
Ephexin1 could influence axonal outgrowth in one of
two possible ways. Ephexin1 could be required either
for the initiation of neurite development or for the pro-
motion of axon outgrowth. As ephexin1−/− RGCs have
a similar number of neurites when compared to wild-
type RGCs, it is unlikely that the initiation of neurite
outgrowth is regulated by ephexin. Furthermore, ephex-
in1 is tethered to the Eph at the plasma membrane of
the growth cone, localizing ephexin1 to the proper
place to regulate the rate of axonal extension.
While in the absence of ephrins ephexin1 promotes
axonal outgrowth, ephrin stimulation of Ephs induces
Src-dependent phosphorylation of ephexin1 on an evo-
lutionarily conserved tyrosine, and this leads to growth
cone collapse. The tyrosine phosphorylation of ephex-
in1 enhances ephexin1’s exchange activity specifically
toward RhoA, thus promoting growth cone collapse/re-
pulsion. Consistent with this idea, we find that ephexin1
is important for ephrin-mediated growth cone collapse
in vitro and axon guidance in vivo. Chicken motor neu-
ron axons in which ephexin has been knocked down
enter the hindlimb prematurely. Since motor neuron
projections into the hindlimb have previously been
shown to be controlled by ephrin/Eph interactions (Eb-
erhart et al., 2002), this result strongly suggests that
ephexin is required for Eph/ephrin-mediated axon guid-
ance in vivo. This defect in axon guidance most likely
reflects impairment in the ability of ephexin-deficient
axonal growth cones to collapse in response to ephrins
in limb mesoderm, as the growth cones of cultured
RGCs from ephexin1−/− mice display a defective col-
lapse response when exposed to ephrin.
In addition to demonstrating that ephexin1 plays a
key role in ephrin-mediated collapse/repulsion, our
findings identify a mechanism by which Ephs regulate
ephexin1, leading to growth cone collapse. The direc-
tional control of axon pathfinding in vivo is thought to
result from local modulation of the actin cytoskeleton
such that growth cones turn away from repellents and
toward attractants. The discoveries that ephexin1 is re-
quired for axon outgrowth, is regulated by tyrosine
phosphorylation, and when tyrosine phosphorylated
promotes growth cone collapse suggest a mechanism
by which Rho GTPases could control the actin cy-
toskeleton in the highly localized manner that is re-
quired for accurate growth cone guidance. Since
ephexin1 is constitutively bound to Ephs, its effects on
Rho GTPases may remain confined to the vicinity of the
Eph complex. Thus, in the absence of ephrin stimula-
tion, Eph/ephexin1 complexes might promote localized
growth cone extension. When Ephs are activated in a
portion of the growth cone by ephrins, local tyrosine
phosphorylation of ephexin1 at Tyr87 could tip the local
balance of GTPase activity toward RhoA, leading to ac-
tin cytoskeletal changes that result in local retraction. In
regions of the growth cone that have not made specific
contact with ephrin, ephexin1 might still promote
growth by activating RhoA, Rac1, and Cdc42. This
could result in directed movement of the growth cone
Neuron
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mate target. C
If ephexin1 bound to Ephs is to play the dual role N
of promoting outgrowth in the absence of ephrins and i
retraction in the presence of ephrins, one might predict d
that ephexin1 may have evolved to specifically interact
with Ephs and not other guidance receptors. For exam- s
ple, if ephexin1 interacted with Ephs and plexins (a re- m
ceptor for the repulsive guidance factor semaphorin) at i
the same time and in the same region of the growth s
cone, conflicting signals might occur depending on the e
presence of ephrins and semaphorins. If ephrin were w
present and semaphorin were not, ephexin1 bound to o
Ephs could signal the growth cone to retract, while s
ephexin1 bound to plexins would signal the growth c
cone to extend. To avoid this problem, ephexins appear e
to have evolved so that they specifically mediate i
ephrin/Eph signaling. Consistent with this idea, we find g
that, of the growth and guidance factors tested, only b
ephrin is able to induce ephexin1 phosphorylation on r
Tyr87. No other guidance molecules (e.g., BDNF, LPA, e
Sema3A, or Nogo66) or growth factors (e.g., PDGF, a
EGF, or insulin) tested led to ephexin1 tyrosine phos- a
phorylation, suggesting that ephexin1 may be specifi- s
cally designed to respond to ephrin signals. Since d
ephexin1 can promote outgrowth in the absence of r
ephrin and repulsion upon encountering ephrins, ephex-
in1 is tailored to mediate ephrin-dependent growth c
cone guidance. r
To better understand the process by which Ephs me- p
diate axon guidance, we investigated how tyrosine a
phosphorylation of ephexin1 switches ephexin1’s ex- i
change activity. Through mutagenesis of ephexin1, we s
found that the isolated DH/PH domain possesses t
strong exchange activity toward RhoA and is ineffective d
at activating Rac1 and Cdc42. In the context of full- p
length ephexin1 when Tyr87 is not phosphorylated, the e
DH/PH domain is capable of activating RhoA, Rac1, W
and Cdc42. This suggests that, in the absence of phos- a
phorylation, other domains of ephexin1 modulate the c
activity of the DH/PH domain so that it no longer prefer- n
entially activates RhoA. Further mutagenesis revealed p
that it is the N terminus that possesses the modulatory p
function. Tyr87 phosphorylation in response to ephrin
h
appears to suppress the modulatory effect of the N ter-
t
minus, resulting in an ephexin1 DH/PH domain that is
2highly selective toward RhoA at the expense of Rac1
sand Cdc42. Consistent with such a model, we find that
tfull-length ephexin1 when not phosphorylated in vitro
Eis capable of activating RhoA, Rac1, and Cdc42. When
dphosphorylated at Tyr87 in vitro, ephexin1’s activity for
wRhoA is specifically enhanced, while its activity toward
oRac1 and Cdc42 is unchanged. This suggests that
twithin cells the phosphorylation of ephexin1 in re-
psponse to Eph activation leads to a potentiation of
RhoA activity and possibly enhances binding to RhoA
so that ephexin1 is unavailable to activate Rac1 and E
Cdc42. Further experimentation will be required to as-
Isess binding affinities of nonphosphorylated and phos-
Rphorylated ephexin1 for RhoA relative to Rac1 and
d
Cdc42. While it is presently not clear how tyrosine (
phosphorylation specifically suppresses the N-terminal 5
modulatory effect on the DH/PH domain, one likely ef- t
cfect is that the N terminus interacts directly with theH/PH domain to modulate DH/PH domain function.
onsistent with this possibility, we find that the isolated
terminus of ephexin is capable of interacting with an
solated fragment of ephexin1 consisting of the DH/PH
omain and the C terminus (data not shown).
While our experiments reveal that ephexin1 plays a
ignificant role in Eph-mediated axon guidance, it re-
ains to be determined whether ephexin1 plays a role
n other Eph-dependent biological processes. One pos-
ibility is that ephexin1 may mediate Eph-dependent
ffects on cell migration and localization. Consistent
ith this possibility, we have found that overexpression
f chicken ephexin leads to aberrant migration of pre-
umptive motor neurons out of the neural tube, a pro-
ess that is dependent on the phosphorylation of
phexin. In addition to migration, Ephs have also been
mplicated in dendritic spine formation. Similar to
rowth cones, dendritic spines are highly motile actin-
ased structures that rapidly alter their morphology in
esponse to various extracellular stimuli (including
phrins). Thus, ephexin family GEFs may mediate some
spects of ephrin-dependent dendritic spine formation
nd/or maintenance. In this regard, our preliminary re-
ults suggest that ephexin5 is highly enriched in den-
ritic spines and thus might play an important role in
egulating dendritic spine formation.
While ephexin1 appears capable of modulating actin
ytoskeletal dynamics during growth cone guidance,
emodeling of the cytoskeleton is not the only cellular
rocess that is required for regulation of axon guid-
nce. The process of axon guidance is a complex event
nvolving endocytosis of plasma membrane and cell
urface proteins, reorganization of the actin cytoskele-
on and microtubules, and local protein translation and
egradation (van Horck et al., 2004). The signaling
athways that link cell surface receptor activation to
ach of these processes are not yet well understood.
hile we have shown that ephexin1 regulates the bal-
nce of GTPase activation, thereby affecting the actin
ytoskeleton during the process of axon guidance, it is
ot yet clear if ephexin1 is involved in other steps in the
rocess of axon guidance such as endocytosis, local
rotein translation, and local protein degradation. We
ave recent evidence that another GEF, Vav2, is impor-
ant for Eph-dependent axon guidance (Cowan et al.,
005 [this issue of Neuron]). In response to ephrin
timulation, Vav2 associates with the Ephs, becomes
yrosine phosphorylated, and plays a role in ephrin/
ph-dependent endocytosis that is a key step in Eph-
ependent axon guidance. It remains to be determined
hether or not ephexin and Vav function independently
f each other and how these two GEFs and other pro-
eins that interact with Ephs coordinate the complex
rocess of axon guidance.
xperimental Procedures
n Vitro Kinase Assays
ecombinant ephexin was incubated with either GST-EphA4 kinase
omain or His-tagged Src (Upstate Biotechnology) in kinase buffer
20 mM Tris 7.5, 8 mM MgCl2, 3 mM MnCl2) with 200 µM ATP and
µCi [γ-32P]ATP for 30 min at 30°C. For trkB kinase assays, Flag-
agged trkB was transfected into HEK293T cells and immunopre-
ipitated with anti-Flag epitope antibody before incubating with
Eph-Dependent Tyrosine Phosphorylation of Ephexin
203ephexin1 in kinase buffer. Samples were electrophoresed on an
SDS-PAGE gel that was subsequently stained with Coomassie blue
and exposed to film.
Fibroblast Morphology Assay
REF-52 cells were maintained in DMEM with 10% newborn calf
serum, glutamine, and Pen/Strep (Invitrogen) and transfected using
Fugene (Roche). Twenty-four to forty-eight hours after transfection,
cells were fixed with 4% paraformaldehyde, permeabilized with
0.1% Triton, and stained with Alexa594-conjugated phalloidin (Mo-
lecular Probes). Cells were scored in a blinded manner.
Growth Cone Collapse Assay and Axon Length Analysis
RGCs were purified and cultured as previously described (Meyer-
Franke et al., 1995). Expression plasmids were electroporated into
RGCs with the rat neuron Nucleofector kit (Amaxa). RGCs that were
cultured for 1–2 days were stimulated with aggregated ephrins for
30 min, fixed in 4% paraformaldehyde, stained with Alexa594-con-
jugated phalloidin (Molecular Probes), and scored for growth cone
collapse in a blinded manner. Ephrin-A1-Fc was aggregated at 5
g/ml 45 min prior to use with 0.45 mg/ml goat anti-human Fc anti-
body (Jackson Laboratories) in Dulbecco’s phosphate-buffered sa-
line (Invitrogen). Pervanadate was prepared as previously de-
scribed (Sun et al., 2000), and RGCs were treated with 10 M
pervanadate for 30 min.
For neurite length analysis of dissociated neurons, neurons were
fixed after 24–36 hr in culture and stained with phalloidin-Texas
red (Molecular Probes). Images blinded to the experimenter were
obtained on a fluorescent microscope and were analyzed using
Metamorph software (Universal Imaging Corporation) by manually
tracing the length of the neurite for at least 50 neurons per condi-
tion. Four independent experiments were conducted for each
mouse strain.
RNA Interference
The full-length chicken ephexin sequence was copied into the
siRNA search engine (http://jura.wi.mit.edu/siRNAext/). Two oligo
sequences against chicken ephexin were generated: 218 and 461.
These regions were not homologous to any other known genes, as
determined by BLAST search. Each sequence was then entered
into a siRNA converter (http://www.ambion.com/techlib/misc/
psilencer_converter.html/), to generate top and bottom oligo se-
quences that were acquired (Sigma-Genosys). C-ephexin 461 top
sequence, 5#-GGCTGTTAGTGAGCGCTTCTTCAAGAGAGAAGCGCTC
ACTAACAGCCTTTTTT-3#; c-ephexin 461 bottom sequence, 5#-
AATTAAAAAAGGCTGTTAGTGAGCTTCTCTCTTGAAGAAGCGCTCA
CTAACAGCCGGCC-3#; c-ephexin 218 top sequence, 5#-GCTCC
AACTCCAGGTTCAACTTCAAGAGAGTTGAACCTGGAGTTGGAG
TTTTTT-3# ; c-ephexin 218 bottom sequence, 5#-AATTAAAAAA
CTCCAACTCCAGGTTCAACTCTCTTGAAGTTGAACCTGGAGTTGG
AGCGGCC-3#. Briefly, the complementary oligonucleotides were
annealed and inserted into the ApaI/EcoRI sites of the pSilencer
1.0 U6 vector (Ambion). Missense shRNAs were generated by
changing three bases in the c-ephexin 218 and 461 constructs.
Mutated bases are underlined: 218 missense, 5#-CTGCAACTAC
AGGTTCACC-3#; 461 missense, 5#-GCCTGTTAGGGAGCGCTAC-3#.
These missense sequences were then subjected to BLAST and
BBSRC query; no similarities to chicken or mammalian sequences
were identified. Missense oligos were annealed and placed in pSi-
lencer 1.0 U6, as described above. All shRNAs were confirmed by
sequence analysis.
Quantification of Ephexin Protein Levels
To quantify ephexin protein levels, the average pixel intensity of
presumptive LMC neurons in unsaturated single optical sections
acquired by confocal microscopy was determined using Fluoview
software (Olympus). Sections acquired from three different treat-
ment conditions were measured: (1) ephexin shRNA-expressing; (2)
missense shRNA-expressing; and (3) pCAX (EGFP)-expressing.
Three readings were performed for each LMC domain on the trans-
fected side and nontransfected side.In Ovo Electroporation
Fertilized White Leghorn chicken eggs (Hy-Line International,
Spencer, IA; Bilbie Aviaries, Ann Arbor, MI) were incubated at 38°C
in a humidified incubator until stage 17 of development. For trans-
fection, 2.0–2.5 g/l of shRNA was coelectroporated with pCAX/
EGFP (2–2.5 g/l) into a ventral quadrant of the neural tube of
stage 17 embryos, as previously described (Eberhart et al., 2002).
For electroporations to express EGFP (2 g/l) or to coexpress
c-ephexin/EGFP or c-ephexin-Y17F/EGFP with EphA4/EGFP, stage
15–17 chick embryos were coelectroporated with 2–2.5 g/l of
each construct. Five 14V (Protech Int., TX) or 19V–22V pulses (BTX/
Genetronics, CA) of 50 ms duration were applied, and several drops
of Ringer’s buffer were added, after which each egg was sealed
with tape and incubated for 6, 12, 24, or 32 hr.
GDP Release Assays
In vitro guanine nucleotide release assays were performed as de-
scribed elsewhere (Debant et al., 1996) using recombinant full-
length ephexin1 with RhoA-His, Rac1-His, and Cdc42-His (Cy-
toskeleton). Briefly, the GTPases were first loaded with 3H-GDP in
exchange buffer (50 mM Tris [pH 7.5], 50 mM NaCl, 5 mM EDTA, 1
mM DTT, 1 mg/ml BSA). After incubation, MgCl2 was added to a
final concentration of 5 mM, and proteins were maintained on ice.
Recombinant ephexin1 was incubated with the GTPase in 50 mM
Tris (pH 7.5), 1 mM GTP, 2 mM MgCl2 at room temperature for 15
min. In the presentation of data, the intrinsic GDP release rate of
the GTPase is taken into account. Thus, “100%” corresponds to
the amount of protein bound 3H-GDP retained on the filter in the
presence of the GTPase alone.
Supplemental Data
The Supplemental Data include three supplemental figures and
Supplemental Experimental Procedures and can be found with this
article online at http://www.neuron.org/cgi/content/full/46/2/191/
DC1/.
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